ZICOM GROUP LIMITED — Capital/Financing Update 2013

Aug 6, 2013

Zicom Gr Limited ABN 62 009 816 871 oup

==> picture [64 x 16] intentionally omitted <==

==> picture [64 x 16] intentionally omitted <==

==> picture [64 x 16] intentionally omitted <==

38 Goodman Place, Murarrie, Queensland 4172 • Tel: (07) 3908 6088 • Fax: (07) 3390 6898

06 August 2013

Market Announcement Office Australian Securities Exchange Level 6, 20 Bridge Street SYDNEY NSW 2000

Dear Sir,

NEW INVESTMENT

The Group is pleased to announce that it has been awarded a grant potentially amounting to S$4.5m by a Singapore government enterprise development agency to undertake intellectual property translation services for medical technology in Singapore.

The Group has formed a new wholly owned subsidiary, iPtec Pte Ltd (iPtec) in Singapore, with an initial paid up capital of S$2m to carry out this new activity. The capital will be fully funded internally.

The services offered by iPtec extend from translating medical technology inventions to tangible prototype medical devices to prove their concept and value, provide industrial product design, support for clinical trials and regulatory approvals, product manufacture and commercialisation efforts.

The main aim of the grant is to support the Group in building up a capability to bridge a gap in the eco-system in the development of medical technology in Singapore. The Group is expected to scale up such capability not only to translate medical technology from Singapore research institutions, hospitals and universities but also to expand it with a global outreach.

The Group has been selected out of about 10 proposals submitted. Our selection has been pivoted by our success in translating medical technology in the last 3 years for start-ups including those which we have invested. The grant will be in the form of a cash subsidy which will be disbursed based on performance milestones over a 3 year period.

iPtec will be run strictly on a commercial basis and aims to break-even in the first year. iPtec hopes to be profitable from the second year. We aim for iPtec to be a catalyst to integrate the Group’s investments in medical technology as part of our sustainable growth strategies.

Yours faithfully Zicom Group Limited

==> picture [36 x 51] intentionally omitted <==

-------------------------------G L Sim Chairman.